Novo Nordisk (United States)
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Novo Nordisk (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
60%
Total
Publications
1.9K
Total Open
Publications
1.2K
Total
Citations
71K
Open Access
Percentage
60%
Total
Publications
1.9K
Total Open
Publications
1.2K
Total
Citations
71K
Breakdown
Publisher Open
15%
Both
32%
Other Platform Open
13%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 44%
398
Hybrid 26%
239
No Guarantees 30%
274
Other Platform Open
Domain 72%
631
Institution 45%
390
Preprint 15%
128
Other Internet 13%
111
Public 3%
30
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 652 |
doaj.org OAI-PMH Repository | Institution | 193 |
bioRxiv | Preprint | 86 |
University of Copenhagen | Institution | 70 |
Unknown Repository | Other Internet | 67 |
DOI | Other Internet | 53 |
California Digital Library | Institution | 31 |
Technical University of Denmark | Institution | 29 |
Figshare | Public | 29 |
medRxiv | Preprint | 26 |